What might you be missing in your point-of-care testing results?

Werfen hosted a breakfast event at the ADLM 2024 Annual Meeting with an Expert Panel, focused on the challenges and impact of invitro hemolysis. A new innovation, the GEM Premier 7000 with iQM3* featuring hemolysis detection, at the point of care, was introduced.

Navigating Hemolysis: Unveiling a New Innovation in Point-of-Care Testing

Featured Speakers

Danyel Tacker, PhD, D(ABCC), FAACC

Clinical Professor of Pathology
West Virginia University
Associate Medical Director of Clinical Laboratories
West Virginia University Hospital, Morgantown, WV

Heather Stieglitz, PhD, DABCC

Clinical Assistant Professor, Dept. of Pathology
The Ohio State University
Division Director for Chemistry, Toxicology, and POC
Testing, The Ohio State University Wexner Medical
Center, Columbus, OH

Robert Maynard, PhD

Assistant Professor of Clinical Pathology
University of Kentucky College of Medicine
Director of POC, Blood Gases, and Special Chemistry
University of Kentucky, Lexington, KY